Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1265 of 5804
-
Smartphone Check-Ins could boost TB treatment success
Disease control OngoingThe gold standard for tuberculosis (TB) treatment support requires directly observed therapy (DOT), which means a trained health worker observes the patient swallow each dose of medication every day for 2 months. Despite the practice of DOT in Malaysia, 1 in 20 patients are loss-…
Phase: NA • Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could delaying kidney implant during heart transplant reduce complications?
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a simple blood test spare lung cancer patients from chemo?
Knowledge-focused Recruiting nowIt is a prospective, multicenter, randomized controlled trial to investigate the predictive value of MRD on adjuvant therapy. Stage IA2-II resected NSCLC patients will undergo two-round MRD tests after surgery, first in 3-7 days and second in 1 month after surgery. And patients w…
Phase: NA • Sponsor: Peking University Cancer Hospital & Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Nerve zap could unclog heart failure lungs
Symptom relief Recruiting nowHeart failure (HF) affects more than 6 million adults in the U.S. alone, with increasing prevalence. Cardiovascular congestion with resultant limitation in physical activity is the hallmark of chronic and decompensated HF. The current HF physiologic model suggests that congestion…
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a blood pressure cuff boost stroke recovery? trial tests the idea
Disease control TerminatedThe primary purpose of this study is to examine whether remote ischemic treatment can better the 90 - day neurological outcomes in acute ischemic stroke patients having severe stenosis or occlusion of anterior intracranial circulation vessels.
Phase: NA • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
One visit, two shots: study tests combining RSV and shingles vaccines
⭐️ VACCINE ⭐️ CompletedThis purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF and HZ/su vaccine when given together in adults 50 years of age and older.
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:56 UTC
-
New study aims to prevent brain damage in newborns by decoding heart rate patterns
Knowledge-focused Recruiting nowSevere neonatal acidosis is an identified risk factor for neonatal encephalopathies and severe neurological sequelae such as cerebral palsy. While intrapartum origin of such deterioration is rare (approximately 20% of adverse outcomes in term infants), screening for hypoxia that …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Could a ZAP to the brain ease chronic pain? new trial tests personalized stimulation
Symptom relief Recruiting nowThis study aims to examine the use of neurostimulation as a potential adjuvant treatment for chronic pain. Among neurostimulation techniques, transcranial direct current stimulation (tDCS) represents a promising, yet not fully exploited, option. Recent methodological advances all…
Phase: NA • Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New robot could improve endometrial cancer surgery
Disease control Recruiting nowProspective Multicenter Observational Study The study involves the consecutive inclusion of every patient with endometrial cancer undergoing staging surgical treatment using a robotic approach with the da Vinci SP platform.
Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 26, 2026 18:49 UTC
-
Can a Cannabis-Derived drug soothe sickle cell pain? new trial aims to find out
Symptom relief Recruiting nowA randomized, double blind, study of dronabinol as a palliative agent in the treatment of pain, inflammation, and other complications of sickle cell disease (SCD).
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New study tracks safety of VYLOY in everyday cancer care
Disease control Recruiting nowThis study is for people in South Korea who have cancer in or around the stomach (gastric cancer) or cancer where the food pipe (esophagus) joins the stomach, called gastroesophageal junction (GEJ) cancer. Their cancer is locally advanced, unresectable, or metastatic. Locally adv…
Sponsor: Astellas Pharma Korea, Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Nasal polyp patients may finally ditch pricey biologics
Disease control Recruiting nowIn this RCT the investigators randomize patients who are treated with biologic treatment (Nucala or Dupixent) due to nasal polyps and have controlled disease within the last year to either stop treatment og continue as a control group.
Phase: PHASE4 • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New obesity drug BGM0504 takes on tirzepatide in Head-to-Head trial
Disease control Recruiting nowTo evaluate the efficacy and safety of BGM0504 compared with Tirzepatide in adult participants who have obesity without diabetes after 26 weeks of treatment.
Phase: PHASE2 • Sponsor: BrightGene Bio-Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Blood Test-Guided dosing may boost depression treatment in kids and adults
Disease control Recruiting nowDepression in childhood and adolescence is a serious and increasing public-health problem associated with profound short- and long-term consequences, including impaired social and educational functioning, increased risk of somatic illness and substance use, and elevated mortality…
Phase: PHASE4 • Sponsor: Poznan University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New depression drug LV232 enters Mid-Stage trial
Symptom relief Recruiting nowThis multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-finding Phase II clinical trial aimed to determine the optimal dose of LV232 capsules for treating MDD, evaluate preliminary efficacy and safety, and provide a basis for Phase III trial design an…
Phase: PHASE2 • Sponsor: Vigonvita Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New implant offers hope for stubborn back pain sufferers
Disease control CompletedThe goal of this observational study is to learn if Nevro1 Sacroiliac Transfixing and Fusion System can treat sacroiliac joint dysfunction in males or females over 21. The main questions it aims to answer is what percentage of patients have clinically important pain relief with n…
Sponsor: Nevro Corp • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could a mild eye zap help restore sight in glaucoma?
Disease control Recruiting nowGlaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glaucoma. The aim of this pilot study is to evaluate the safety and effectiveness of the treatment of visual field defects …
Phase: NA • Sponsor: Okuvision GmbH • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Fatty liver drug hope: semaglutide shows promise in Long-Term study
Disease control OngoingThis real-world clinical trial evaluates the effectiveness of semaglutide (target dose is 2.4 mg/week) over 154 weeks (3 years) prescribed to the patients with metabolic dysfunction-associated fatty liver disease (MAFLD) and liver fibrosis (stages 0-4) as a part of routine clinic…
Sponsor: Center of target therapy • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New combo therapy targets tough lung cancers
Disease control Recruiting nowThis is a Phase Ib clinical study conducted in China to evaluate the treatment of advanced non-small cell lung cancer with JSKN016 in combination therapy. The enrolled subjects are all in the locally advanced or metastatic stage of non-small cell lung cancer.
Phase: PHASE1 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood test may spot lingering lung cancer earlier
Knowledge-focused Recruiting nowThis study aims to evaluate the utility of combined plasma SHOX2 and PTGER4 gene methylation analysis as a dynamic biomarker for monitoring minimal residual disease (MRD) and predicting recurrence in postoperative non-small cell lung cancer (NSCLC) patients. The primary objective…
Sponsor: Beijing Haidian Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC